Concepedia

Author

C. Houzard

Hospices Civils de Lyon

Also Known As

C HOUZARD, C Houzard, C. HOUZARD, C. Houzard, CLAIRE HOUZARD, Christian Scheiber, Claire Houzard, Houzard, C., Houzard, Claire

89

Publications

1.2K

Citations

17

H-Index

36

Concepts

All Affiliations

Hospices Civils de LyonInsermUniversité Claude Bernard Lyon 1Hôpital Lyon SudAssistance Publique – Hôpitaux de Paris
CH

About

C. Houzard is an author at Hospices Civils de Lyon specializing in medicine, health sciences, and radiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

182

2

Health Sciences

3

3

158

3

Engineering

1

1

11

4

Endocrinology

1

1

13

5

Immunology

1

1

13

C. Houzard

×

22

Publications

1.1K

Citations

17

H-Index

YearCitations

Imaging Work-Up for Screening of Paraganglioma and Pheochromocytoma in<i>SDHx</i>Mutation Carriers: A Multicenter Prospective Study from the PGL.EVA Investigators

Anne‐Paule Gimenez‐Roqueplo, Aurore Caumont‐Prim, C. Houzard,

The Journal of Clinical Endocrinology & Metabolism

2012

156

Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy.

Rachida Lebtahi, J. Le Cloirec, C. Houzard,

PubMed

2002

88

Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by <sup>18</sup>F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study)

Pierre Véra, S. Thureau, Philippe Chaumet‐Riffaud,

Journal of Nuclear Medicine

2017

81

Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study

Carole Guérin, François Pattou, Laurent Brunaud,

The Journal of Clinical Endocrinology & Metabolism

2017

74

Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1

L. Képénékian, Thomas Mognetti, Jean‐Christophe Lifante,

European Journal of Endocrinology

2016

67

Prospective comparison of MR lung perfusion and lung scintigraphy

Y. Berthez�ne, Pierre Croisille, Marlène Wiart,

Journal of Magnetic Resonance Imaging

1999

66

Somatostatin receptor imaging in somatotroph and non‐functioning pituitary adenomas: correlation with hormonal and visual responses to octreotide

Françoise Borson‐Chazot, C. Houzard, Christiane Ajzenberg,

Clinical Endocrinology

1997

62

FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2)

Pierre Véra, S. Mezzani-Saillard, Agathe Edet‐Sanson,

European Journal of Nuclear Medicine and Molecular Imaging

2014

58

Added value of <sup>18</sup>F‐florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study

Mathieu Ceccaldi, Thérèse Jonveaux, Antoine Verger,

Alzheimer s & Dementia

2017

54

The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3)

O. Palié, Pierre Michel, Jean-François Ménard,

European Journal of Nuclear Medicine and Molecular Imaging

2013

52

Page 1